The Therapeutic Goods Administration is a Commonwealth Government agency that regulates medical devices and drugs. Prescription medicines and over-the-counter medicines which meet Australian standards of quality, safety and efficacy are included on the Australian Register of Therapeutic Goods. Medicines may be registered or listed. Registered products are thoroughly evaluated and are labelled with an AUST R number. Listed products, such as complementary medicines, do not have to undergo the same assessments and are labelled with an AUST L number. They are not routinely evaluated before marketing, but are subject to a random audit after listing. Some medicines, such as those compounded for individual patients, are not regulated.
Introduction
The Therapeutic Goods Administration (TGA) is a division of the Australian Department of Health and Ageing. Its principal role is as the national regulator of therapeutic goods -a collective term covering medicines, medical devices and some related products. The TGA administers the Therapeutic Goods Act 1989, the objects of which include 'a national system of controls relating to the quality, safety, efficacy and timely availability of therapeutic goods that are used in Australia, whether produced in Australia or elsewhere, or exported from Australia'. These activities are fully funded by fees charged for assessments, annual registrations and inspections.
Australian Register of Therapeutic Goods
The lawful supply of any therapeutic good in Australia requires that the product is included on the Australian Register of Therapeutic Goods (ARTG). There are two types of entry on the 
AUST R products
Medicines that are registered include:
■ almost all prescription medicines ■ a number of products, such as vaccines, which although not classified in law as needing a prescription warrant detailed evaluation ■ almost all conventional over-the-counter medicines including, for example, packs of aspirin and paracetamol tablets sold from supermarkets ■ a very small number of complementary medicines where the TGA has been satisfied that specific claims of efficacy in treatment or prevention of a disease are supported by adequate evidence.
The approval of AUST R products is based on satisfactory assessments of their quality, efficacy and safety.
Prescription medicines
The Australian system for the pre-registration evaluation of 
Over-the-counter medicines
Nowadays, almost all active substances in non-prescription medicines first enter the market as ingredients of prescription medicines. To assess whether or not an active substance is suitable for use in a non-prescription medicine usually requires the substance to have been used for at least two years as a prescription medicine. Not all active substances make the transition from prescription to over-the-counter use. The volume of new information to support efficacy and safety is usually less, because the registration of the over-the-counter product can draw on the accumulated experience as a prescription product.
New over-the-counter products are assessed by the TGA for quality, efficacy and safety. The standards for such things as quality and circumstances of manufacture are essentially the same as those of prescription medicines.
AUST L products
The AUST L medicines must:
• not contain substances that are prohibited imports, come from endangered species or be covered by the national regulations which control access to many substances (Standard for the Uniform Scheduling of Drugs and Poisons)
• conform with lists of permitted ingredients (minerals, vitamins, declared listable substances).
In some instances, there are additional requirements such as dose limits, specified label warnings and limits on plant parts or methods of preparation. Certain herbs are not permitted.
The initial approach to regulation of AUST L products did not require evidence to support manufacturers' claims, provided the products were not for the treatment of serious illnesses.
A concern that multiple and at times improbable claims were 
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